A framework for monitoring RSV prevention product effectiveness in the United States.
Roper LE, Link-Gelles R, Surie D, DeCuir J, Zambrano LD, Prill MM, Havers FP, Jones JM, Melgar M, Hall AJ, Whitehead RD Jr, McMorrow ML, Ioannou GN, Hernandez-Romieu AC, Britton A, Novosad S, Martin A, Feldstein LR, Bajema KL, Kirking H, Moline H, Campbell AP, Aslan M, Hatfield K, Dawood F, Slayton R, Reddy S, Gomes D, Fleming-Dutra KE, Payne AB.
Roper LE, et al. Among authors: campbell ap.
Vaccine. 2025 Jan 2;45:126633. doi: 10.1016/j.vaccine.2024.126633. Online ahead of print.
Vaccine. 2025.
PMID: 39755055